Alloy Therapeutics, Inc.

📍 Boston, United States🗓 Founded 2017👥 136 employees💰 Last funded Feb 2025
Biotechnology Research🌐 alloytx.com
Website LinkedIn
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. From licensing our platforms, to working with us as a trusted discovery service partner, we have collaborated with over 170+ partners and counting including 18 of Fortune 50 Biopharmaceutical companies to enable the discovery of their next breakthrough biologic medicines. With Alloy, you can: • Access our ever-growing stable of antibody and bispecific discovery platforms that blend in vivo and in vitro wet-lab capabilities with AI/ML. Discover with us through our services or by licensing our technologies for use in your lab. • Unlock intracellular targets with the therapeutic potential of T cell receptor (TCR) modalities through our fully integrated Keyway™ TCRm discovery service offering. • Reach genetic disease targets at the nucleic acid level with our novel AntiClastic™ ASO Format, which enhances the molecules potency while minimizing off-target interaction and inflammatory response. • Co-build new biotechnology companies that leverage our core platforms and service capabilities with Alloys affiliated Venture Studio, 82VS. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Boston, MA, with labs in Cambridge, U.K.; Basel, CH; and Athens, GA. We reinvest 100% of our revenue back into innovation and access to innovation. Reach out, follow, and visit our website, to learn more about how we can make better medicines, together. https://www.alloytx.com/
10
Total investors
3
Early stage
6
Mid stage
1
Late stage
2017
Founded

Investors

10 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
9
United Kingdom
1
Investor activity2018–2025 · investors recorded per year
20183202152022120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Alloy Therapeutics, Inc.?
Alloy Therapeutics, Inc. has 10 investors on record on gritt.io, including 3 early-stage backers, 6 mid-stage and 1 late-stage investors.
When did Alloy Therapeutics, Inc. last raise funding?
The most recent investment in Alloy Therapeutics, Inc. recorded on gritt.io was in February 2025.
When was Alloy Therapeutics, Inc. founded?
Alloy Therapeutics, Inc. was founded in 2017.
What industry is Alloy Therapeutics, Inc. in?
Alloy Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Alloy Therapeutics, Inc. based?
Alloy Therapeutics, Inc. is headquartered in Boston, United States.